January 2021 - Evolution Biotechnologies
0
archive,date,ajax_fade,page_not_loaded,,qode-title-hidden,qode-theme-ver-16.4,qode-theme-bridge,wpb-js-composer js-comp-ver-5.4.7,vc_responsive

Evolution Biotechnologies announces presentation at Bioseed Investment Event, to be held virtually on 21 January 2021 Bedford, UK, January 9th, 2021 Evolution Biotechnologies (www.evolutionbiotech.com), the UK based company pioneering the use of biological control to benefit human health, today announced its intention to present at the OBN BioSeed Investment Event on 21st January 2021. CEO Dr. David Harper will present a summary of the company’s activities and the progression of its technology. About Evolution Biotechnologies: Evolution Biotechnologies (UK company 09473027) is working to extend the application of biological control from its proven efficacy in agriculture into biomedical markets. The company’s initial target is the...